EC gives nod for Clinigen to update Cardioxane advice
Clinigen Group
925.00p
16:39 04/04/22
0.00%
0.00p
Global pharmaceutical and services company Clinigen Group announced on Thursday that its commercial medicines operation has received European Commission approval to update the current product information for Cardioxane.
Food & Drug Retailers
3,705.02
17:10 19/04/24
0.60%
22.15
FTSE AIM 100
3,595.66
17:08 19/04/24
n/a
n/a
FTSE AIM 50
3,943.93
17:08 19/04/24
n/a
n/a
FTSE AIM All-Share
745.67
17:08 19/04/24
n/a
n/a